NuCana plc ( NCNA) - Stock Earnings
NCNA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.3 million USD | — USD |
| 2026Q1 | -5.1 million USD | — USD |
| 2026Q2 | -4.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NCNA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -35.2 million USD | — USD |
| 2024 | -23.8 million USD | — USD |
| 2025 | -39.4 million USD | — USD |
| 2026 Est. | — | — |
NCNA
Price: $1.14
52 week price:
Earnings Per Share: 65.09 USD
P/E Ratio: 0.02
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 46300
Market Capitalization: 8.5 million